Navigation Links
Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors
Date:2/15/2011

ir damaged and dying dopamine-secreting neurons, keeping them alive and restoring normal function. Neurturin is a member of the same protein family as glial cell-derived neurotrophic factor (GDNF).  The two molecules have similar pharmacological properties, and both have been shown to benefit the midbrain dopamine neurons that degenerate in Parkinson's disease.  Degeneration of these neurons is responsible for the major motor impairments of Parkinson's disease.  CERE-120 has been delivered by stereotactic injection to the terminal fields (i.e., the ends of the degenerating neurons), located in an area of the brain called the putamen.  The cell bodies for these same neurons are located in a different area of the brain, called the substantia nigra.  Once CERE-120 is delivered to the brain, it provides stable, long-lasting expression of neurturin in a highly targeted fashion.

About the Current CERE-120 (AAV2-NRTN) Clinical Trial

Ceregene has an ongoing Phase 1/2 clinical trial of CERE-120 (AAV-neurturin) in patients with Parkinson's disease.  Enrollment in the Phase 2b portion of this clinical trial is active at 11 centers across the US.  The goal of this clinical trial is to evaluate the safety and potential benefits of CERE-120 (AAV-neurturin) in the treatment of Parkinson's disease.

Approximately 52 people with Parkinson's disease will participate in this clinical trial.  Half of the study subjects will undergo brain surgery to receive CERE-120, while the other half will undergo a similar surgery without receiving any CERE-120 injections ("sham" or "mock" surgery).  Participants will be carefully monitored by an expert team of study doctors and nurses for three years after the study surgery.  Unless their medical condition prohibits it, all patients who initially receive the sham surgery in this trial will be offered CERE-120 when the trial is completed, assuming the data obtained
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
2. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease
3. SeraCare Reports First Quarter Fiscal Year 2011 Results
4. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
5. YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
6. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results
7. ERT Reports Fourth Quarter and Full Year 2010 Operating Results on March 1, 2011
8. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
9. Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Second Quarter 2011
10. Codexis Reports Fourth Quarter and Full Year 2010 Results
11. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched ... tinnitus. Patients listen to sound therapy that is tailor-made ... weeks to months, their tinnitus volume decreases. , AudioNotch has ... and Notched White Noise. Now, AudioNotch is pleased to announce ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Histogen, Inc., ... products of cells grown under simulated embryonic conditions, today ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic products ... , This agreement is an amendment to the ...
(Date:1/14/2014)... The largest international professional organization of scientists ... derivatives thereof has endorsed an educational program that ... challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural Product ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... who hope to create quantum computers are currently investigating ... diamond show promise for encoding quantum bits (qubits), but ... extremely weak signal. Now physicists have demonstrated a roundabout ... sorts of qubits. Their experiment is reported in the ...
... ... Proprietary PatentRatings® System,World’s Most Inventive Companies Are Ranked Based on Patent Quality, Not Quantity ... Chicago, IL ... announced the results of a proprietary study performed for Bloomberg BusinessWeek. , , , ...
... , Jan. 19 HistoRx, Inc. ... Carroll to the newly created position of Vice President, ... years of sales, marketing, research, and general management experience in ... in 2009, he was Vice President of Clinical Research for ...
Cached Biology Technology:Turning down the noise in quantum data storage 2Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 2Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 3Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 4HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research 2HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research 3
(Date:4/24/2014)... they often inject harmful proteins into the host ... However, in some plants, bacteria attack once they,ve ... Now, researchers at the University of Missouri have ... bacteriaknown mostly for attacking tomatoesto invade its host. ... that work with food-producing plants to enhance resistance ...
(Date:4/24/2014)... a commercially important sugar used as a sweetener, ... for synthesizing riboflavin and several antiviral drugs. Genetic ... the bacteria,s ability to produce D-ribose is a ... of this valuable chemical, as described in an ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/24/2014)... Entomological Society of America (ESA) is very pleased to ... Journal of Insect Science from the University of ... is an international, open-access, peer-reviewed journal that ... insects and other arthropods -- from the molecular to ... medical impacts. It is freely available to individuals and ...
Breaking Biology News(10 mins):Plants send out signals attracting harmful bacteria, MU study finds 2ESA to publish the Journal of Insect Science 2
... steps for controlling plant growth, Australian researchers have shown ... wall regulates growth of root hairs. Root hairs are ... and water from the soil. The research will assist ... industries such as, agriculture, horticulture and forestry. ...
... When Hansel and Gretel ventured into the forest, ... way home. In today,s world, cellular phones, Global Positioning ... that connect us to friends, family, and colleagues while ... Yet, despite the ubiquity of such devices, with ...
... The world,s first three-dimensional plasmon rulers, capable ... have been developed by researchers with the U.S. ... (Berkeley Lab), in collaboration with researchers at the ... could provide scientists with unprecedented details on such ...
Cached Biology News:Not just another brick in the (plant cell) wall 2Wireless 'breadcrumbs' that won’t become toast when baked...or soggy when hosed 2Wireless 'breadcrumbs' that won’t become toast when baked...or soggy when hosed 3Taking the 3-D measure of macromolecules: 2Taking the 3-D measure of macromolecules: 3
...
...
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions....
Rad 50 Immunogen: c-terminal mRad 50 (604 amino acids). Storage: 4 C...
Biology Products: